It is, therefore, tempting to speculate that mutations in VAPB, TDP-43, and FUS may contribute to ALS pathogenesis by interfering with energy metabolism at the level of ER–mitochondria interactions. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.